Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), mean decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), mean decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
-
281
-
282
Table_1_Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2.docx
Published 2022“…Here we describe two fully human mAbs, amubarvimab (BRII-196) and romlusevimab (BRII-198) that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein and effectively neutralize SARS-CoV-2 variants. …”
-
283
-
284
-
285
-
286
-
287
-
288
Trends in the numbers of syphilis cases in WHO-WPRO: China, New Zealand, Australia, and Japan.
Published 2024Subjects: -
289
-
290
-
291
The number of cases of syphilis by classification in Japan showing as 100% stacked bar chart.
Published 2024Subjects: -
292
-
293
-
294
-
295
-
296
-
297
-
298
Annual treatment frequencies in recurrence and non-recurrence groups.
Published 2025“…In the non-recurrence group, the respective preoperative treatment counts were 2.6 ± 1.1, 0.5 ± 0.9, 0.6 ± 0.9, 0.1 ± 0.3, and 3.8 ± 1.3, and no additional treatments were required during the 3 postoperative years. …”
-
299
-
300